Another strategy to avoid BCMA-negative relapses involves the combination of BCMA CAR-T cells with gamma-secretase inhibitors which prevent cleavage of BCMA from the MM cell surface [50]. This evidence concerns the gene TNFRSF17 and Miyoshi myopathy.